Afatinib in NSCLC harbouring EGFR mutations.
Division of Thoracic Oncology, European Institute of Oncology, 20141 Milan Italy.
Filippo
F
de Marinis
Division of Thoracic Oncology, European Institute of Oncology, 20141 Milan Italy.
Chiara
C
Catania
Division of Thoracic Oncology, European Institute of Oncology, 20141 Milan Italy. Electronic address: a-passaro@hotmail.it.
Antonio
A
Passaro
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D044466:Asian People / Q000235:genetics*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D066246:ErbB Receptors / Q000235:genetics*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D066246:ErbB Receptors